---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033314"
form_type: "8-K"
ticker: "BIXT"
cik: "0001445815"
company_name: "BIOXYTRAN, INC"
filed_at: "2024-08-20T23:59:59+00:00"
generated_at: "2026-05-31T08:27:05.266579+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bioxytran issues 28.97M preferred shares to insiders, converts 94M common shares and $354K debt

## Summary
- Issued 28,971,248 convertible preferred shares to insiders in exchange for 94,057,658 common shares at a 5:1 ratio.
- Preferred shares have super voting rights: vote on 'as if converted' basis multiplied by 2; insiders now control 77.9% voting power.
- Conversion also extinguished $353,840 in accrued salaries, accounts receivable, and short-term debt plus 14.41M subsidiary shares.
- Common shares outstanding reduced to 81,850,495; par value $0.001 per share; listed on OTCQB.
- Press release announces peer-reviewed British Journal article on carbon monoxide in mitochondria, using MDX Viewer to validate BXT-25.

## SEC filing metadata
- accession: 0001493152-24-033314
- form_type: 8-K
- ticker: BIXT
- cik: 0001445815
- company_name: BIOXYTRAN, INC
- filed_at: 2024-08-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1445815/000149315224033314/0001493152-24-033314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1445815/000149315224033314/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033314
- JSON: https://secwatch.observer/filing/0001493152-24-033314.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.